Companies

Universe Pharmaceuticals INC

UPC · CIK 0001809616 · other

$2.64-1.12%Last updated Mar 4, 8:56 PM

Key Statistics

Valuation

Market Cap$1.49M
P/E
Fwd P/E
PEG
P/S0.08
P/B0.03
EV/EBITDA9.53
EV/Rev-1.28

Profitability

Gross Margin
Op. Margin
Net Margin
ROE
ROA
FCF Margin

Financial Health

Current Ratio
Debt/Equity
Free Cash Flow
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta1.57
52W High$11
52W Low$2.51

About Universe Pharmaceuticals INC

Through its subsidiaries, this company manufactures and distributes traditional Chinese medicine derivative products in China, serving pharmaceutical companies, hospitals, clinics, and drugstore chains. Its product portfolio includes branded medications targeting common chronic health conditions in elderly populations, physical wellness, and acute illnesses such as colds and flu. Specific offerings encompass medicinal liquors, syrups, granules, and oral preparations, such as paracetamol granule for children and isatis root granule.

The company also operates a distribution business for third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. This segment provides additional revenue diversification beyond its proprietary traditional Chinese medicine derivative lines.

Headquartered in Ji'An, China, the company operates with approximately 216 full-time employees. It was founded in 1998 and operates as a subsidiary of Sununion Holding Group Limited. The company is incorporated in China and listed on Nasdaq.

Annual Reports (10-K) · 0 filings

No 10-K filings found.